Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma
Background Osteosarcoma is a highly aggressive cancer, and the efficacy of existing therapies has plateaued. Multiomics integration analysis can identify novel therapeutic targets for various cancers and therefore shows potential toward osteosarcoma treatment. This study aimed to leverage multiomics...
Saved in:
| Main Authors: | Yan Liao, Hao Yao, Weidong Chen, Yutong Zou, Ji Fang, Jiongfeng Zhang, Zehao Guo, Jian Tu, Junkai Chen, Zijun Huo, Lili Wen, Xianbiao Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/8/e011091.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma
by: Yan Zeng, et al.
Published: (2025-08-01) -
MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness
by: Aviran Aharon, et al.
Published: (2025-04-01) -
Placental network differences among obstetric syndromes identified with an integrated multiomics approach
by: Samantha N. Piekos, et al.
Published: (2025-08-01) -
CSN6 aggravates inflammation and Myocardial injury in macrophage of sepsis model by MIF
by: Qianying Song, et al.
Published: (2025-07-01) -
Integrated single-cell analysis reveals heterogeneity and therapeutic insights in osteosarcoma
by: Dongan He, et al.
Published: (2024-11-01)